Fenofibrate

Description

Elevating Cardiovascular Health with Fenofibrate Capsules from PharmAlliance International Labs

Welcome to PharmAlliance International Labs Private Limited, your trusted partner in advancing global healthcare through innovative pharmaceutical solutions. We are delighted to introduce our Fenofibrate Range, meticulously crafted to combat lipid disorders and champion cardiovascular well-being. With a steadfast commitment to excellence and patient-centric care, we strive to redefine standards in pharmaceutical innovation and efficacy.

Unveiling the Mechanism: Pharmacokinetics and Pharmacodynamics

Fenofibrate, a stalwart in our pharmaceutical armamentarium, belongs to the esteemed class of fibric acid derivatives. Its mechanism of action hinges on the activation of peroxisome proliferator-activated receptor alpha (PPAR-alpha), a pivotal regulator of lipid metabolism. By harnessing this mechanism, fenofibrate orchestrates a multifaceted approach to lipid management, fostering lipolysis, curbing triglyceride synthesis, and augmenting HDL cholesterol levels, all while modestly tempering LDL cholesterol levels.

Embracing the Drug Class:

As a lipid-lowering agent, fenofibrate stands as a beacon of hope for individuals grappling with hyperlipidemia and dyslipidemia. Its versatility extends to patients with elevated triglyceride levels and mixed dyslipidemia, often complementing lifestyle modifications and adjunctive lipid-lowering therapies.

Tailored Formulations for Optimal Efficacy:

Our Fenofibrate Range manifests in capsule form, each encapsulating 200 mg of fenofibrate, meticulously calibrated to deliver therapeutic efficacy in managing lipid disorders and safeguarding cardiovascular health.

Navigating Indications with Precision:

Fenofibrate capsules are indispensable in the management of hypertriglyceridemia, offering respite to individuals burdened by Fredrickson Types IV and V hyperlipidemia. Additionally, fenofibrate emerges as a cornerstone in the treatment of mixed dyslipidemia and holds promise in atherosclerosis prevention, particularly in patients at heightened cardiovascular risk.

Navigating Dosage and Usage:

To unlock the full potential of fenofibrate, adherence to prescribed dosages and administration guidelines is paramount. Typically, initiation entails a daily dose ranging from 145 mg to 200 mg, with dosage titration guided by individual lipid profiles and therapeutic objectives.

Navigating Potential Side Effects:

While fenofibrate boasts a favorable safety profile, vigilance against potential side effects remains imperative. Gastrointestinal disturbances, headaches, and myopathy represent among the most commonly reported adverse events. Prompt medical consultation is warranted in the event of severe or persistent manifestations.

Packaging Specifications:

Our Fenofibrate capsules are thoughtfully packaged in blister packs housing 30 capsules each, underscoring our commitment to convenience, compliance, and patient-centric care.

Embark on a transformative journey towards optimal cardiovascular health with Fenofibrate Capsules from PharmAlliance International Labs. Trust in our unwavering dedication to pharmaceutical excellence and patient well-being. For comprehensive insights and guidance, we invite you to explore our website or engage with your healthcare provider.